Page 50 - E Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

IndiaJ&J COVID-19 vaccine expected to be imported to India by July - report Reuters 3 minutes read Johnson & Johnson's (JNJ.N) single-shot COVID-19 vaccine is expected to be imported to India for "fill and finish" by June or July, financial daily Mint reported on Friday, citing ANI. Fill and finish is the final step in the manufacturing process of putting the vaccine into vials or syringes, sealing them and packaging them up for shipping. India has said it would fast-track emergency approvals for COVID-19 vaccines authorised by Western countries and Japan, paving the way for possible imports ...

Johnson & Johnson COVID-19 vaccine likely to be imported by July Johnson & Johnson vaccines are expected to be imported to India by June-July 2021 Johnson & Johnson is working closely with Biological E to facilitate the ongoing tech transfer to India, Renu Swarup, Secretary, Department of Biotechnology said Reuters | April 23, 2021 | Updated 11:04 IST Johnson & Johnson's single-shot COVID-19 vaccine is expected to be imported to India for "fill and finish" by June or July, financial daily Mint reported on Friday, citing ANI. Fill and finish is the final step in the manufacturing process of ...

  >>  Reuters Published: 23 Apr 2021 05:29 PM BdST Updated: 23 Apr 2021 05:29 PM BdST Johnson & Johnson's coronavirus disease (COVID-19) vaccines are kept refrigerated at the Forem vaccination centre in Pamplona, Spain, Apr 22, 2021. REUTERS Johnson & Johnson's single-shot COVID-19 vaccine is expected to be imported to India for "fill and finish" by June or July, financial daily Mint reported on Friday, citing ANI. "); } Fill and finish is the final step in the manufacturing process of putting the vaccine into vials or syringes, sealing them and packaging them up for shipping. India has...

Why Moderna, Pfizer, others could take time to enter Indian market despite govt's fast-track approach Even as the Centre fast-tracked the process of emergency approval of vaccines already cleared by the drug regulators of the US, UK, EU, Japan and the WHO, global commitments of these pharma companies may lead to delays in their entry into Indian market. advertisement UPDATED: April 15, 2021 00:19 IST The pharma companies have already committed a large chunk of vaccines to the US as well as the EU. (Image: PTI) The Indian government on Tuesday decided to fast-track the process of emergency app...

India will approve the use of all COVID-19 vaccines that have been given an emergency nod by the WHO or regulators in the U.S., Europe, Britain or Japan.